tirzepatide and methotrexate autoimmune disease: what the research actually shows Retatrutide vs Tirzepatide: Key Differences

Packaged in a resealable bag

When prescribing therapies to patients living with obesity (PwO) the median total weight loss (TWL) gives a good indication of the likely utility of prescription for that individual

It was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the UK and represents a significant step forward in medically supervised weight management

At 50% uptake, and assuming a 15.5% discontinuation rate as observed in the SOUL trial, an estimated 59,332 MACE, 14,215 cardiovascular deaths, 41,744 nonfatal myocardial infarctions, and 12,260 nonfatal strokes could be prevented

Increases your metabolism

Discover the correct dosing frequency, injection timing, what happens if you miss a dose, and why daily administration is essential for effective weight management treatment in the UK.